Serotyping for an extended anticitrullinated peptide autoantibody panel does not add value to CCP2 testing for diagnosing RA in an early undifferentiated arthritis cohort

Annals of the Rheumatic Diseases

Volumn 70, Issue 11, 2011, Pages 2056-2058

  Pratt, Arthur G ^a,b   Charles, Peter J ^c   Chowdhury, Muslima ^c   Wilson, Gillian ^b   Venables, Patrick J ^c   Isaacs, John D ^a,b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CITRULLINATED FIBRINOGEN ANTIBODY; CITRULLINATED VIMENTIN ANTIBODY; CYCLIC CITRULLINATED ALPHA ENOLASE PEPTIDE 1 ANTIBODY; CYCLIC CITRULLINATED ALPHA ENOLASE PEPTIDE 11 ANTIBODY; CYCLIC CITRULLINATED ALPHA ENOLASE PEPTIDE ANTIBODY; CYCLIC CITRULLINATED PEPTIDE 2 ANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYCLIC PRO FILAGGRIN DERIVED PEPTIDE ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; LINEAR CITRULLINATED FILAGGRIN PEPTIDE ANTIBODY; PEPTIDE ANTIBODY; RHEUMATOID FACTOR; UNCLASSIFIED DRUG; AUTOANTIBODY; BIOLOGICAL MARKER; CYCLIC CITRULLINATED PEPTIDE; CYCLOPEPTIDE;

ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; INTERMETHOD COMPARISON; LETTER; MAJOR CLINICAL STUDY; ONSET AGE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SEROTYPING; BLOOD; EARLY DIAGNOSIS; FOLLOW UP; IMMUNOLOGY;

ADULT; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BIOLOGICAL MARKERS; EARLY DIAGNOSIS; FOLLOW-UP STUDIES; HUMANS; PEPTIDES, CYCLIC;

EID: 80053561011     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2010.148197     Document Type: Letter

References (10)

1. van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, et al. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum 2004;50:709-15. (Pubitemid 38326168)
2. Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010;62:2569-81.
3. van Dongen H, van Aken J, Lard LR, et al. Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebocontrolled trial. Arthritis Rheum 2007;56:1424-32. (Pubitemid 46764069)
4. Wegner N, Lundberg K, Kinloch A, et al. Autoimmunity to specific citrullinated proteins gives the first clues to the etiology of rheumatoid arthritis. Immunol Rev 2010;233:34-54.
5. Schellekens GA, De Jong BA, van den Hoogen FH, et al. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 1998;101:273-81. (Pubitemid 28058927)
6. Arnett FC, Edworthy SM, Bloch DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24. (Pubitemid 18091653)
7. Lundberg K, Kinloch A, Fisher BA, et al. Antibodies to citrullinated alpha-enolase peptide 1 are specific for rheumatoid arthritis and cross-react with bacterial enolase. Arthritis Rheum 2008;58:3009-19.
8. Snir O, Widhe M, Von Spee C, et al. Multiple antibody reactivities to citrullinated antigens in sera from patients with rheumatoid arthritis: association with HLA-DRB1 alleles. Ann Rheum Dis 2009;68:736-43.
9. Harrison BJ, Symmons DP, Brennan P, et al. Natural remission in inflammatory polyarthritis: issues of definition and prediction. Br J Rheumatol 1996;35:1096-100.
10. Tunn EJ, Bacon PA. Differentiating persistent from self-limiting symmetrical synovitis in an early arthritis clinic. Br J Rheumatol 1993;32:97-103. (Pubitemid 23077692)